ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

May 10, 2013

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994

Duke Deans Acknowledge Withholding Key Document From Outside Reviewers

January 14, 2011

Funding Opportunities.

April 12, 2002

Vanderbilt Wins NCI Core Grant Renewal with 12.7 Percent Funding increase

December 3, 2010

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005